These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6160777)

  • 21. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
    Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
    Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy of head and neck cancer.
    Holoye PY; Byers RM; Gard DA; Goepfert H; Guillamondegui OM; Jesse RH
    Cancer; 1978 Oct; 42(4):1661-9. PubMed ID: 81714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
    Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for head and neck cancer relapsing after radiotherapy.
    Cortes EP; Kalra J; Amin VC; Attie J; Eisenbud L; Khafif R; Wolk D; Aral I; Sciubba J; Akbiyik N; Heller K
    Cancer; 1981 Apr; 47(8):1966-70. PubMed ID: 6164476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
    Chiuten D; Vogl SE; Kaplan BH; Greenwald E
    Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J; Oster MW
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
    Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
    Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for advanced carcinoma of head and neck: an effective outpatient schedule of Cytoxan, Oncovin, methotrexate and bleomycin.
    Didolkar MS; Coleman JJ; Elias EG; Gray WC; Cosentino E
    Head Neck Surg; 1981; 4(2):92-7. PubMed ID: 6171546
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
    Wittes RE; Spiro RH; Shah J; Gerold FP; Koven B; Strong EW
    Med Pediatr Oncol; 1977; 3(3):301-9. PubMed ID: 85249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
    Argiris A; Haraf DJ; Kies MS; Vokes EE
    Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
    Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
    Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
    Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-containing chemotherapy in advanced head and neck cancer.
    Paterson IC; Quilty PM
    Clin Radiol; 1985 Nov; 36(6):607-10. PubMed ID: 2415291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.